Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINC1 | P01008 | 2/20 | 0.40 |
| ▸ | F10 | P00742 | 5/20 | 0.34 |
| ▸ | FGF1 | P05230 | 4/20 | 0.34 |
| ▸ | FGF2 | P09038 | 1/20 | 0.31 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6855783 | 0.69 | SERPINC1 (0.38) | SERPINC1F10FGF1FGF2HPSE | |
| SCHEMBL17902153 | 0.67 | SERPINC1 (0.39) | SERPINC1FGF1 | |
| SCHEMBL17521735 | 0.65 | SERPINC1 (0.40) | SERPINC1F10FGF1 | |
| SCHEMBL16316488 | 0.65 | FGF1 (0.64) | SERPINC1F10FGF1FGF2HPSE | |
| Idraparinux SCHEMBL29382311 | 0.63 | SERPINC1 (0.85) | SERPINC1F10FGF1FGF2HPSE | |
| Idraparinux SCHEMBL427808 | 0.63 | SERPINC1 (0.85) | SERPINC1F10FGF1FGF2HPSE | |
| SCHEMBL29407493 | 0.63 | SERPINC1 (0.85) | SERPINC1F10FGF1FGF2HPSE | |
| SCHEMBL12729453 | 0.62 | SERPINC1 (0.74) | SERPINC1F10FGF1FGF2HPSE | |
| SCHEMBL2961028 | 0.61 | FGF1 (0.59) | SERPINC1F10FGF1FGF2HPSE | |
| SCHEMBL2960806 | 0.61 | FGF1 (0.59) | SERPINC1F10FGF1FGF2HPSE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011073408-A2 | PHARMACEUTICAL ORAL DOSAGE FORM CONTAINING A SYNTHETIC OLIGOSACCHARIDE | ENDOTIS PHARMA (FR) | 2011-06-23 | — | — | WO | disclosed |